# WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure Control

Study · id `cardio:ct-nct07523269` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07523269](<https://clinicaltrials.gov/study/NCT07523269>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07523269

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 164 participants.

## Technical summary

Registry record NCT07523269. Randomized; no masking; primary purpose other. Start 2026-04 (anticipated); primary completion 2027-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 164 participants (planned count; ClinicalTrials.gov record NCT07523269, source copy `cardio:ctgov-nct07523269-2026-04-13`, retrieved 2026-10-26)
- Planned start: 2026-04 (anticipated) (ClinicalTrials.gov record NCT07523269, source copy `cardio:ctgov-nct07523269-2026-04-13`, retrieved 2026-10-26)
- Primary completion: 2027-09 (anticipated) (ClinicalTrials.gov record NCT07523269, source copy `cardio:ctgov-nct07523269-2026-04-13`, retrieved 2026-10-26)
- Completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT07523269, source copy `cardio:ctgov-nct07523269-2026-04-13`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07523269, source copy `cardio:ctgov-nct07523269-2026-04-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07523269-2026-04-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure Control
- Acronym: WEARABLE-BP
- Condition: Hypertension (HTN)
- Intervention (Device): Aktiia G1 BP monitor for 12 months
- Intervention (Device): Traditional BP monitor for 6 months / Aktiia G1 BP monitor for 6 months
- Lead sponsor: Aktiia SA
- Lead sponsor class: INDUSTRY
- Collaborator: Massachusetts General Hospital
- Collaborator class: OTHER
- Collaborator: Brigham and Women's Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Aktiia SA (`cardio:org-aktiia-sa`)
- Registry lists this organization as a collaborator: Massachusetts General Hospital (`cardio:org-massachusetts-general-hospital`)
- Registry lists this organization as a collaborator: Brigham and Women's Hospital (`cardio:org-brigham-and-women-s-hospital`)

## Provenance

Content hash: f2dafc97e8a49d83c2574a869bc19914a4f3604f3c096aadec3b29dd7ef70540
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
